In 1986 THC was licensed as an anti-emetic drug in cancer patients receiving chemotherapy
In 1986, delta-9-tetrahydrocannabinol (THC), the main effective constituent of cannabis, was licensed as an anti-emetic drug in cancer patients receiving chemotherapy. In addition, in clinical studies, THC has shown significant stimulation of appetite and an increase in body weight in HIV-positive and cancer patients.
Understanding Cannabinoids: THC (Tetrahydrocannabinol)
Cannabinoid Hyperemesis Syndrome
Ecuador Sets Hemp Delta 9 THC Limit at 1.0% & Approves Medical Cannabis
The government of Ecuador has set the maximum Delta 9 THC level for industrial hemp at a full 1%, following the lead of Uruguay, Switzerland, and Australia.
Middle-Aged Man Died After Using Legal Tainted Vape Cartridge
Tainted vape cartridges have yet again claimed another victim. A middle-aged man from Oregon has died from a mysterious lung condition after vaping THC oil that he’d bought from a dispensary.